XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer
Clinical trial NCT00215722 · UNKNOWN
Trial details
- NCT number
- NCT00215722
- Sponsor
- Grupo de Investigacao do Cancro Digestivo
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.